Pere Domingo Selected Research

PPAR gamma

10/2012	Adipogenic/lipid, inflammatory, and mitochondrial parameters in subcutaneous adipose tissue of untreated HIV-1-infected long-term nonprogressors: significant alterations despite low viral burden.
9/2009	PPARgamma Pro12Ala polymorphism in HIV-1-infected patients with HAART-related lipodystrophy.
11/2006	Altered expression of master regulatory genes of adipogenesis in lipomas from patients bearing tRNA(Lys) point mutations in mitochondrial DNA.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pere Domingo Research Topics

Disease

51	Infections 02/2024 - 09/2003
41	Lipodystrophy 01/2022 - 08/2002
33	Acquired Immunodeficiency Syndrome (AIDS) 04/2024 - 04/2003
28	HIV Infections (HIV Infection) 05/2020 - 03/2002
23	Inflammation (Inflammations) 03/2024 - 03/2008
17	COVID-19 02/2024 - 01/2021
17	Insulin Resistance 01/2023 - 10/2003
10	Obesity 01/2023 - 09/2009
7	Cardiovascular Diseases (Cardiovascular Disease) 10/2023 - 03/2015
7	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022 - 01/2007
7	Disease Progression 01/2022 - 04/2003
7	Liver Cirrhosis (Hepatic Cirrhosis) 10/2018 - 01/2007
6	Hypertension (High Blood Pressure) 10/2023 - 01/2010
6	Dyslipidemias (Dyslipidemia) 01/2022 - 07/2004
6	Fibrosis (Cirrhosis) 01/2022 - 02/2012
6	Coinfection 10/2021 - 01/2007
6	Exanthema (Rash) 10/2018 - 10/2004
4	Weight Gain 01/2023 - 01/2020
4	Neoplasms (Cancer) 01/2022 - 11/2010
4	Osteoporosis 05/2018 - 12/2014
4	Chronic Renal Insufficiency 01/2015 - 01/2014
4	Lipomatosis 01/2015 - 04/2004
4	Necrosis 01/2012 - 01/2006
3	Pneumonia (Pneumonitis) 12/2022 - 08/2009
3	Meningitis 11/2020 - 01/2002
3	Hypertriglyceridemia 01/2018 - 04/2004
3	Metabolic Bone Diseases (Osteopenia) 01/2017 - 12/2014
3	Opportunistic Infections (Opportunistic Infection) 10/2016 - 05/2012
3	Hepatitis C 04/2014 - 11/2004
3	Hypercholesterolemia 07/2013 - 04/2004
3	Hypertrophy 01/2013 - 08/2007
3	Tuberculosis (Tuberculoses) 01/2011 - 11/2005
3	Viremia 04/2010 - 09/2005
2	Heart Failure 01/2023 - 12/2021
2	Thrombophilia 01/2023 - 12/2021
2	Meningococcal Infections 01/2019 - 01/2002

Drug/Important Bio-Agent (IBA)

17	RNA (Ribonucleic Acid)IBA 02/2024 - 09/2003
14	LipidsIBA 03/2024 - 09/2003
13	Protease Inhibitors (Protease Inhibitor)IBA 10/2023 - 09/2003
10	Biomarkers (Surrogate Marker)IBA 01/2023 - 11/2010
10	NucleosidesIBA 01/2020 - 03/2002
10	Ritonavir (Norvir)FDA Link 01/2017 - 11/2005
9	CytokinesIBA 01/2022 - 12/2004
9	Reverse Transcriptase InhibitorsIBA 01/2020 - 03/2002
9	abacavir (Ziagen)FDA Link 12/2016 - 06/2002
9	efavirenz (Sustiva)FDA Link 02/2012 - 02/2002
8	dolutegravirIBA 10/2023 - 11/2013
8	Messenger RNA (mRNA)IBA 01/2022 - 11/2006
8	Triglycerides (Triacylglycerol)IBA 01/2018 - 10/2003
7	AdipokinesIBA 11/2022 - 01/2006
7	Antiviral Agents (Antivirals)IBA 01/2022 - 06/2015
7	Tenofovir (Viread)FDA Link 01/2022 - 07/2004
7	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018 - 01/2007
7	Lopinavir FDA Link 07/2015 - 01/2007
7	Stavudine (Zerit)FDA LinkGeneric 01/2014 - 07/2004
6	Proteins (Proteins, Gene)FDA Link 12/2022 - 01/2009
6	Raltegravir Potassium FDA Link 11/2022 - 11/2009
6	Interleukin-6 (Interleukin 6)IBA 10/2021 - 04/2008
6	fibroblast growth factor 21IBA 10/2018 - 11/2010
6	Lamivudine (Epivir)FDA Link 07/2015 - 11/2005
5	Glucose (Dextrose)FDA LinkGeneric 03/2024 - 11/2010
5	AdiponectinIBA 01/2023 - 01/2006
4	Integrase InhibitorsIBA 10/2023 - 03/2015
4	C-Reactive ProteinIBA 01/2022 - 01/2015
4	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2018 - 01/2010
4	Mitochondrial DNA (mtDNA)IBA 08/2014 - 07/2004
4	Insulin (Novolin)FDA Link 12/2012 - 01/2007
3	RacivirIBA 01/2022 - 01/2015
3	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2021 - 10/2018
3	ThymidineIBA 01/2020 - 07/2009
3	lamivudine drug combination abacavir FDA Link 01/2017 - 04/2006
3	Interleukin-18 (Interleukin 18)IBA 10/2013 - 05/2012
3	stavudine triphosphateIBA 01/2013 - 04/2010
3	HDL CholesterolIBA 12/2012 - 01/2007
3	PPAR gammaIBA 10/2012 - 11/2006
3	Zidovudine (Retrovir)FDA LinkGeneric 01/2012 - 10/2008
3	Nevirapine (Viramune)FDA Link 08/2011 - 09/2003
3	Didanosine (Videx)FDA LinkGeneric 01/2009 - 11/2005
3	Rifampin (Rifampicin)FDA LinkGeneric 04/2007 - 10/2004
2	Antihypertensive Agents (Antihypertensives)IBA 10/2023 - 01/2023
2	tenofovir alafenamideIBA 01/2023 - 01/2022
2	bictegravirIBA 11/2022 - 10/2021
2	VaccinesIBA 01/2022 - 07/2005
2	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2022 - 06/2015
2	Glycoproteins (Glycoprotein)IBA 01/2022 - 05/2020
2	Hepatitis C AntibodiesIBA 01/2022 - 03/2016
2	Surface Antigens (Surface Antigen)IBA 01/2022 - 07/2015
2	Emtricitabine (Emtriva)FDA Link 01/2022 - 07/2015
2	Immunologic Factors (Immunomodulators)IBA 11/2021 - 10/2021
2	fibrin fragment D (D-dimer)IBA 10/2021 - 06/2015
2	Dexamethasone (Maxidex)FDA LinkGeneric 06/2021 - 12/2004
2	Darunavir (Prezista)FDA Link 01/2020 - 02/2011
2	Anti-Retroviral Agents (Antiretroviral Agents)IBA 01/2020 - 01/2010
2	Rilpivirine (TMC-278)IBA 01/2020 - 06/2012

Therapy/Procedure

66	Therapeutics 01/2023 - 01/2002
46	Highly Active Antiretroviral Therapy (HAART) 05/2022 - 08/2002
5	Art Therapy 04/2024 - 01/2018
2	Aftercare (After-Treatment) 12/2022 - 01/2007
2	Length of Stay 12/2022 - 07/2022
2	Artificial Respiration (Mechanical Ventilation) 10/2021 - 07/2021